
    
      1. Patients with moderate to severe UC will be screened (Mayo>6ï¼‰.

        2. Participants will be divided into control and study groups by double blind.

        3. Control group and study group will receive a colonic endoscopy evaluation. And a TET
           tube will be fixed at ileocecum.

        4. Enema with 5-ASA 4g/day for 7days by TET will be performed as basic therapy for both
           control and study group. Study and control group will be given with fecal microbiota
           suspension and equal volume of saline by TET for three times every other day in one
           week.

        5. The follow-up will be performed at 1 week, 4 weeks and 12 weeks after first treatment.
           All the participants will receive a endoscopy evaluation at 12 weeks. Clinical
           remission, clinical improvement and safety are the primary endpoint at 12 weeks;
           Intestinal microbiota changing is recognized as the secondary endpoint.
    
  